Annual Current Liabilities
$53.28 M
+$28.16 M+112.11%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total current liabilities is $53.28 million, with the most recent change of +$28.16 million (+112.11%) on December 31, 2023.
- During the last 3 years, EIGR annual current liabilities has risen by +$36.66 million (+220.47%).
- EIGR annual current liabilities is now at all-time high.
Performance
EIGR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$53.28 M
+$36.76 M+222.46%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total current liabilities is $53.28 million, with the most recent change of +$36.76 million (+222.46%) on December 31, 2023.
- Over the past year, EIGR quarterly current liabilities has increased by +$28.16 million (+112.11%).
- EIGR quarterly current liabilities is now at all-time high.
Performance
EIGR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EIGR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +112.1% | +112.1% |
| 3 y3 years | +220.5% | +220.5% |
| 5 y5 years | +431.6% | +431.6% |
EIGR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +112.1% | at high | +222.5% |
| 5 y | 5-year | at high | +220.5% | at high | +296.7% |
| alltime | all time | at high | +2896.8% | at high | +2865.2% |
Eiger BioPharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $53.28 M(+112.1%) | $53.28 M(+222.5%) |
| Sep 2023 | - | $16.52 M(-1.1%) |
| Jun 2023 | - | $16.71 M(-30.4%) |
| Mar 2023 | - | $24.00 M(-4.5%) |
| Dec 2022 | $25.12 M(-16.0%) | $25.12 M(-3.8%) |
| Sep 2022 | - | $26.12 M(+19.6%) |
| Jun 2022 | - | $21.85 M(-40.3%) |
| Mar 2022 | - | $36.61 M(+22.4%) |
| Dec 2021 | $29.90 M(+79.8%) | $29.90 M(+35.8%) |
| Sep 2021 | - | $22.01 M(+38.7%) |
| Jun 2021 | - | $15.88 M(-9.4%) |
| Mar 2021 | - | $17.52 M(+5.4%) |
| Dec 2020 | $16.63 M(-1.9%) | $16.63 M(-23.2%) |
| Sep 2020 | - | $21.66 M(+34.1%) |
| Jun 2020 | - | $16.15 M(+20.2%) |
| Mar 2020 | - | $13.43 M(-20.7%) |
| Dec 2019 | $16.95 M(+69.1%) | $16.95 M(+1.2%) |
| Sep 2019 | - | $16.75 M(+25.7%) |
| Jun 2019 | - | $13.32 M(+23.0%) |
| Mar 2019 | - | $10.82 M(+8.0%) |
| Dec 2018 | $10.02 M | $10.02 M(-31.1%) |
| Sep 2018 | - | $14.54 M(+64.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $8.83 M(+17.7%) |
| Mar 2018 | - | $7.50 M(+3.2%) |
| Dec 2017 | $7.27 M(+37.5%) | $7.27 M(+26.8%) |
| Sep 2017 | - | $5.73 M(-2.7%) |
| Jun 2017 | - | $5.89 M(+43.8%) |
| Mar 2017 | - | $4.10 M(-22.5%) |
| Dec 2016 | $5.29 M(+129.0%) | $5.29 M(-1.1%) |
| Sep 2016 | - | $5.35 M(+91.7%) |
| Jun 2016 | - | $2.79 M(-65.6%) |
| Mar 2016 | - | $8.11 M(+251.3%) |
| Dec 2015 | $2.31 M(-65.0%) | $2.31 M(+28.5%) |
| Sep 2015 | - | $1.80 M(-89.3%) |
| Jun 2015 | - | $16.84 M(+174.5%) |
| Mar 2015 | - | $6.13 M(-7.1%) |
| Dec 2014 | $6.61 M(+0.7%) | $6.61 M(+34.5%) |
| Sep 2014 | - | $4.91 M(+33.9%) |
| Jun 2014 | - | $3.67 M(-7.4%) |
| Mar 2014 | - | $3.96 M(-39.6%) |
| Dec 2013 | $6.56 M(+269.0%) | $6.56 M(+101.2%) |
| Sep 2013 | - | $3.26 M(+34.7%) |
| Jun 2013 | - | $2.42 M |
| Dec 2012 | $1.78 M(-88.4%) | - |
| Dec 2011 | $15.33 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual current liabilities year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly current liabilities year-on-year change?
What is Eiger BioPharmaceuticals annual total current liabilities?
The current annual current liabilities of EIGR is $53.28 M
What is the all time high annual current liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total current liabilities is $53.28 M
What is Eiger BioPharmaceuticals annual current liabilities year-on-year change?
Over the past year, EIGR annual total current liabilities has changed by +$28.16 M (+112.11%)
What is Eiger BioPharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of EIGR is $53.28 M
What is the all time high quarterly current liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total current liabilities is $53.28 M
What is Eiger BioPharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, EIGR quarterly total current liabilities has changed by +$28.16 M (+112.11%)